Literature DB >> 26932576

PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.

S H M Pang1,2, M Minnich3, P Gangatirkar1,2, Z Zheng1, A Ebert3, G Song4, R A Dickins1,2, L M Corcoran1,2, C G Mullighan4, M Busslinger3, N D Huntington1,2, S L Nutt1,2, S Carotta1,2.   

Abstract

The Ets family transcription factor PU.1 and the interferon regulatory factor (IRF)4 and IRF8 regulate gene expression by binding to composite DNA sequences known as Ets/interferon consensus elements. Although all three factors are expressed from the onset of B-cell development, single deficiency of these factors in B-cell progenitors only mildly impacts on bone marrow B lymphopoiesis. Here we tested whether PU.1 cooperates with IRF factors in regulating early B-cell development. Lack of PU.1 and IRF4 resulted in a partial block in development the pre-B-cell stage. The combined deletion of PU.1 and IRF8 reduced recirculating B-cell numbers. Strikingly, all PU.1/IRF4 and ~50% of PU.1/IRF8 double deficient mice developed pre-B-cell acute lymphoblastic leukemia (B-ALL) associated with reduced expression of the established B-lineage tumor suppressor genes, Ikaros and Spi-B. These genes are directly regulated by PU.1/IRF4/IRF8, and restoration of Ikaros or Spi-B expression inhibited leukemic cell growth. In summary, we demonstrate that PU.1, IRF4 and IRF8 cooperate to regulate early B-cell development and to prevent pre-B-ALL formation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26932576      PMCID: PMC5179358          DOI: 10.1038/leu.2016.27

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  62 in total

1.  Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65.

Authors:  H Jumaa; B Wollscheid; M Mitterer; J Wienands; M Reth; P J Nielsen
Journal:  Immunity       Date:  1999-11       Impact factor: 31.745

2.  Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis.

Authors:  Seung-Hee Jo; Jonathan H Schatz; Jaime Acquaviva; Harinder Singh; Ruibao Ren
Journal:  Blood       Date:  2010-06-28       Impact factor: 22.113

3.  Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Jinghui Zhang; Charles G Mullighan; Richard C Harvey; Gang Wu; Xiang Chen; Michael Edmonson; Kenneth H Buetow; William L Carroll; I-Ming Chen; Meenakshi Devidas; Daniela S Gerhard; Mignon L Loh; Gregory H Reaman; Mary V Relling; Bruce M Camitta; W Paul Bowman; Malcolm A Smith; Cheryl L Willman; James R Downing; Stephen P Hunger
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

4.  PU.1 opposes IL-7-dependent proliferation of developing B cells with involvement of the direct target gene bruton tyrosine kinase.

Authors:  Darah A Christie; Li S Xu; Shereen A Turkistany; Lauren A Solomon; Stephen K H Li; Edmund Yim; Ian Welch; Gillian I Bell; David A Hess; Rodney P DeKoter
Journal:  J Immunol       Date:  2014-12-10       Impact factor: 5.422

5.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

Authors:  Runqing Lu; Kay L Medina; David W Lancki; Harinder Singh
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

6.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors.

Authors:  César Cobaleda; Wolfram Jochum; Meinrad Busslinger
Journal:  Nature       Date:  2007-09-12       Impact factor: 49.962

7.  Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.

Authors:  Hassan Jumaa; Lukas Bossaller; Karina Portugal; Bettina Storch; Michael Lotz; Alexandra Flemming; Martin Schrappe; Ville Postila; Pekka Riikonen; Jukka Pelkonen; Charlotte M Niemeyer; Michael Reth
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

8.  PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.

Authors:  Wendy D Cook; Benjamin J McCaw; Christopher Herring; Deborah L John; Simon J Foote; Stephen L Nutt; Jerry M Adams
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

9.  A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.

Authors:  Ulrich Steidl; Christian Steidl; Alexander Ebralidze; Björn Chapuy; Hye-Jung Han; Britta Will; Frank Rosenbauer; Annegret Becker; Katharina Wagner; Steffen Koschmieder; Susumu Kobayashi; Daniel B Costa; Thomas Schulz; Karen B O'Brien; Roel G W Verhaak; Ruud Delwel; Detlef Haase; Lorenz Trümper; Jürgen Krauter; Terumi Kohwi-Shigematsu; Frank Griesinger; Daniel G Tenen
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  IRF4 is a suppressor of c-Myc induced B cell leukemia.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; James Eudy; Kay-Uwe Wagner; Shantaram S Joshi; Runqing Lu
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

View more
  19 in total

1.  Janus Kinase Mutations in Mice Lacking PU.1 and Spi-B Drive B Cell Leukemia through Reactive Oxygen Species-Induced DNA Damage.

Authors:  Michelle Lim; Carolina R Batista; Bruno R de Oliveira; Rachel Creighton; Jacob Ferguson; Kurt Clemmer; Devon Knight; James Iansavitchous; Danish Mahmood; Mariano Avino; Rodney P DeKoter
Journal:  Mol Cell Biol       Date:  2020-08-28       Impact factor: 4.272

2.  Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory Networks.

Authors:  Adam J Rubin; Kevin R Parker; Ansuman T Satpathy; Yanyan Qi; Beijing Wu; Alvin J Ong; Maxwell R Mumbach; Andrew L Ji; Daniel S Kim; Seung Woo Cho; Brian J Zarnegar; William J Greenleaf; Howard Y Chang; Paul A Khavari
Journal:  Cell       Date:  2018-12-20       Impact factor: 41.582

3.  The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.

Authors:  Angela Su; Frank Ling; Camille Lobry; Kris C Wood; Raphael Itzykson; Alexandre Puissant; Camille Vaganay; Gaetano Sodaro; Chaïma Benaksas; Reinaldo Dal Bello; Antoine Forget; Bryann Pardieu; Kevin H Lin; Justine C Rutter; Christopher F Bassil; Gael Fortin; Justine Pasanisi; Iléana Antony-Debré; Gabriela Alexe; Jean-François Benoist; Alain Pruvost; Yana Pikman; Jun Qi; Marie-Hélène Schlageter; Jean-Baptiste Micol; Giovanni Roti; Thomas Cluzeau; Hervé Dombret; Claude Preudhomme; Nina Fenouille; Lina Benajiba; Hava M Golan; Kimberly Stegmaier
Journal:  Cancer Discov       Date:  2020-08-21       Impact factor: 39.397

4.  Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.

Authors:  H Goto; R Kariya; E Kudo; Y Okuno; K Ueda; H Katano; S Okada
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

5.  Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression.

Authors:  Kun Zhang; Dong-Wen Lv; Renfeng Li
Journal:  Virology       Date:  2019-11-11       Impact factor: 3.616

6.  Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses.

Authors:  Hongsheng Wang; Shweta Jain; Peng Li; Jian-Xin Lin; Jangsuk Oh; Chenfeng Qi; Yuanyuan Gao; Jiafang Sun; Tomomi Sakai; Zohreh Naghashfar; Sadia Abbasi; Alexander L Kovalchuk; Silvia Bolland; Stephen L Nutt; Warren J Leonard; Herbert C Morse
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-18       Impact factor: 11.205

7.  IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.

Authors:  Dennis Das Gupta; Christoph Paul; Nadine Samel; Maria Bieringer; Daniel Staudenraus; Federico Marini; Hartmann Raifer; Lisa Menke; Lea Hansal; Bärbel Camara; Edith Roth; Patrick Daum; Michael Wanzel; Marco Mernberger; Andrea Nist; Uta-Maria Bauer; Frederik Helmprobst; Malte Buchholz; Katrin Roth; Lorenz Bastian; Alina M Hartmann; Claudia Baldus; Koichi Ikuta; Andreas Neubauer; Andreas Burchert; Hans-Martin Jäck; Matthias Klein; Tobias Bopp; Thorsten Stiewe; Axel Pagenstecher; Michael Lohoff
Journal:  Cell Death Differ       Date:  2022-04-22       Impact factor: 15.828

8.  Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.

Authors:  Carolina R Batista; Michelle Lim; Anne-Sophie Laramée; Faisal Abu-Sardanah; Li S Xu; Rajon Hossain; Gillian I Bell; David A Hess; Rodney P DeKoter
Journal:  Blood Adv       Date:  2018-11-13

9.  Spontaneous loss of B lineage transcription factors leads to pre-B leukemia in Ebf1+/-Bcl-xLTg mice.

Authors:  J A Ramírez-Komo; M A Delaney; D Straign; K Lukin; M Tsang; B M Iritani; J Hagman
Journal:  Oncogenesis       Date:  2017-07-10       Impact factor: 7.485

10.  Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13.

Authors:  Ming Yu; Salma Al-Dallal; Latifa Al-Haj; Shiraj Panjwani; Akina S McCartney; Sarah M Edwards; Pooja Manjunath; Catherine Walker; Alexander Awgulewitsch; Kathryn E Hentges
Journal:  Genesis       Date:  2016-08-29       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.